Market Access News | pharmaphorum

News

Illustration of a nerve cell on a colored background with light effects

Competition for Neurocrine as Gocovri picks up new Parkinson...

Adamas Pharmaceuticals’ Parkinson’s drug Gocovri has a new indication as an adjunctive treatment for levodopa/carbodopa in patients with Parkinson’s disease experiencing ‘off’ episodes.

News

BMS eyes May FDA verdict for MS drug Zeposia in ulcerative c...

Bristol-Myers Squibb’s commercial hopes for new multiple sclerosis drug Zeposia have yet to bear fruit thanks to the pandemic, but it’s already cued up a second indication for the would-be

News

AstraZeneca to supply nine million more vaccines to EU

The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses.

News

The unprecedented challenge of pricing a coronavirus vaccine

EMA approves AZ’s COVID-19 vaccine – including for over-65s

The EMA has approved AstraZeneca’s COVID-19 vaccine for use in the EU in all adults aged over 18, despite assertions in Germany this week that it shouldn’t be used in elderly people.

News

AZ has 'constructive talks' with EU leaders after vaccine ro...

AstraZeneca has said it has had “constructive talks” with European leaders in a bid to cool the row over vaccine supplies to the EU.

News

NICE reverses stance on Celgene’s Revlimid for myeloma maint...

NHS patients in England with newly-diagnosed multiple myeloma can be treated with Celgene’s Revlimid as maintenance therapy after a stem cell transplant, after new guidance from NICE.

Competition for Neurocrine as Gocovri picks up new Parkinson...

BMS eyes May FDA verdict for MS drug Zeposia in ulcerative c...

AstraZeneca to supply nine million more vaccines to EU

EMA approves AZ’s COVID-19 vaccine – including for over-65s

AZ has 'constructive talks' with EU leaders after vaccine ro...

NICE reverses stance on Celgene’s Revlimid for myeloma maint...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks